2023 Virus-like Particle & Nano-Particle Vaccines Conference
ExpreS2>/sup>ion scientists attend the 6th VLPNPV meeting on Virus-Like Particles, the multiprotein structures that mimic native viruses but lack the […]
ExpreS2>/sup>ion scientists attend the 6th VLPNPV meeting on Virus-Like Particles, the multiprotein structures that mimic native viruses but lack the […]
Join CFO Keith Alexander for a live update at Aktiespararna’s Småbolagsdagarna in Stockholm. You can stream the event live or […]
Meet ExpreS2ion CEO, Bent Frandsen, at the largest global biotechnology industry event. More information and registration can be found on […]
ExpreS2ion CEO Bent U. Frandsen and CFO Keith Alexander will discuss the 2023 first quarter interim results and answer investors’ […]
ExpreS2ion CEO Bent Frandsen will present ExpreS2ion to investors and potential investors. Registration is possible via the event website
ExpreS2ion pre-clinical development partner University of Bologna will present “Preclinical activity of ES2B-C001, a human candidate HER-2 virus-like particle (VLP) […]
ExpreS2ion CFO Keith Alexander will present ExpreS2ion to investors and potential investors. Registration is possible via the Swiss Nordic Bio […]
ExpreS2ion CEO Bent U. Frandsen and CFO Keith Alexander will discuss the 2023 Rights Issue and answer investors’ questions about […]
ExpreS2ion CEO Bent U. Frandsen and CFO Keith Alexander will discuss the 2022 fourth quarter and full-year results and answer […]
The Biotech Showcase is being held 9-11 January at the Hilton San Francisco Union Square, in San Francisco, California, USA. […]